AR and neoplasm: These mechanisms may include androgen receptor (AR) signaling, activation of prosurvival pathways, and the acquisition of a cancer stem cell morphology.5, 6, 7, 8 Further, tumor immune microenvironment and overexpression of inflammation‐associated molecules have an important role in the development of Doc resistance.7, 8